Explore evidence

171 cells/mm³Median CD4+ cell count at enrollment among people living with HIV increased from 171 cells/mm³ in 2005–2006 to 289 cells/mm³ in 2013–2014.

KenyaVIH/sidaobserved 2005–2006published 2020PloS onePubMeddocument of 12 observations

1.5 yearsThe median estimated time since HIV infection among adolescent girls and young women who self-identify as female sex workers in Mombasa, Kenya, was 1.5 years prior to entry into formal sex work.

KenyaVIH/sidapublished 2023AIDS (London, England)PubMeddocument of 3 observations

7 %In Kenya, MTCT infection rates accounted for 7% of all new infant infections globally by the end of 2015.

KenyaVIH/sidaobserved 2015published 2020African Journal of Health SciencesOpenAlexdocument of 9 observations

41.7 %Treatment interruptions ≥48 hours during the past 6 months were reported by 41.7% of patients in Kenya.

KenyaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 14 observations

75 %Early infant diagnosis (EID) of HIV, followed by effective care including antiretroviral therapy (ART), reduces HIV progression by 75%.

KenyaVIH/sidapublished 2021BMC public healthPubMeddocument of 11 observations

0.89 %Among 4708 PLHIV initiated on IPT in Kenya between July 2015 and June 2018, 42 (0.89%) developed active tuberculosis.

Kenyatuberculose · VIH/sidaobserved July 2015 to June 2018published 2020PloS onePubMeddocument of 8 observations

17.4 %Uptake of Early Infant Male Circumcision (EIMC) was 17.4% for all male infants born in four counties of western Kenya between 1st March 2014 and 31st March 2018.

KenyaVIH/sidaobserved 1st March 2014 through 31st March 2018published 2021African health sciencesPubMeddocument of 3 observations

48.42 odds_ratioHIV infection without antiretroviral therapy (ART) use was associated with ocular surface squamous neoplasia (OSSN) with an odds ratio of 48.42.

Kenyaocular surface squamous neoplasia (OSSN) · VIH/sidapublished 2016Tropical medicine & international health : TM & IHeurope_pmcdocument of 10 observations

1 %1% of 1,234 new samples from the Ivory Coast, Kenya, South Africa, Thailand, and the United States were identified as elite neutralizers.

Afrique du Sud · Côte d'Ivoire · KenyaVIH/sidapublished 2009Journal of virologyeurope_pmcdocument of 2 observationsDOI 10.1128/jvi.00110-09

3.7 %At 3 years, 3.7% of children were living with HIV.

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations

10 %10% of enrolled participants were HIV-positive.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 7 observations

The Mobile WAChX trial evaluates an interactive semiautomated SMS text messaging intervention to improve adherence to antiretroviral therapy and retention in care among peripartum women infected with HIV in Kenya to reduce the mother-to-child transmission of HIV.

KenyaVIH/sidapublished 2020JMIR mHealth and uHealthPubMeddocument of 12 observations

81 %Among 16 HIV seroconverters in the POWER study, 13 (81%) either did not have PrEP dispensed in the study interval prior to seroconversion or had TFV-DP levels indicating <4 doses per week in the prior 6 weeks.

KenyaVIH/sidapublished 2022Journal of the International AIDS SocietyPubMeddocument of 12 observations

3.57 odds_ratioParticipants who had previously used fingerprint biometric systems for identification had an odds ratio of 3.57 for accepting fingerprint technology in an HIV care and treatment facility in Western Kenya.

KenyaVIH/sidapublished 2021Journal of medical Internet researchPubMeddocument of 11 observations

37 %Among 187 participants with second-line viral failure, major PI resistance prevalence was 37%.

KenyaVIH/sidaobserved 2011 to 2021published 2025Journal of the International AIDS SocietyPubMeddocument of 15 observations

5.2 %Women in Kenya have an HIV prevalence rate of 5.2%.

KenyaVIH/sidapublished 2025AIDS research and therapyPubMeddocument of 6 observations

At 1 year of age, HEU infants had higher language scores and comparable scores in fine motor, gross motor and social scores compared to HUU infants using the Malawi developmental assessment tool.

KenyaVIH/sidapublished 2024BMJ openPubMeddocument of 4 observations

888 recordsOf the 1,154 medical records abstracted, 888 (76%) were from adolescent girls and young women seeking HIV treatment.

KenyaVIH/sidapublished 2023Frontiers in public healthPubMeddocument of 9 observations

4 %Among the 1178 clients reached for follow-up, 4% (42/1178) tested HIV-positive and reported ART referral.

KenyaVIH/sidaobserved March to June 2022published 2025BMC health services researchPubMeddocument of 13 observations

85 %At 48 weeks, viral suppression was 85% in the intervention group and 86% in the control group.

KenyaVIH/sidaobserved 48 weekspublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

17.7 %Only 17.7% of HIV-positive adolescents had electricity at home.

KenyaVIH/sidapublished 2020Reproductive healthPubMeddocument of 8 observations

1.5 %Cumulative mortality incidence among children and adolescents initiating antiretroviral therapy in central Kenya was 1.5% at 36 months.

KenyaVIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations

627 individualsThe potential number of new HIV diagnoses through hotspot-based rapid testing in Mombasa, Kenya was 627.

KenyaVIH/sidapublished 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 11 observations

54 %Within 1 month of diagnosis, 54% of 30 HIV-positive children had started antiretroviral treatment.

KenyaVIH/sidapublished 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 7 observations

20 %Each additional year of ART use reduced the likelihood of persistent detection of A9 HR-HPV by 20% among Kenyan women living with HIV.

KenyaA9 HR-HPV · VIH/sidapublished 2021International journal of STD & AIDSPubMeddocument of 5 observations